Tilak Mandadi Cvs Health Corp (CVS) insider trading activity

CVS Quotes by TradingView

Tilak Mandadi is EVP, Chief Technology Officer of CVS HEALTH Corp. Currently has a direct ownership of 40,414 shares of CVS, which is worth approximately $2.61 Million. The most recent transaction as insider was on Aug 31, 2024, when has been sold 13,097 shares (Common Stock) at a price of $57.24 per share, resulting in proceeds of $749,672. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.4K
51.25% 3M change
99.78% 12M change
Total Value Held $2.61 Million

Tilak Mandadi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 31 2024
SELL
Payment of exercise price or tax liability
$749,672 $57.24 p/Share
13,097 Reduced 24.48%
40,414 Common Stock
Apr 01 2024
BUY
Grant, award, or other acquisition
-
16,339 Added 16.46%
82,904 Common Stock (RSU)
Aug 31 2023
SELL
Payment of exercise price or tax liability
$850,664 $65.17 p/Share
13,053 Reduced 39.22%
20,229 Common Stock
Aug 31 2022
BUY
Grant, award, or other acquisition
-
99,847 Added 50.0%
99,847 Common Stock (RSU)

Also insider at

MGM
MGM Resorts International Consumer Cyclical
CSITO
TM

Tilak Mandadi

EVP, Chief Technology Officer
Las Vegas, NV

Track Institutional and Insider Activities on CVS

Follow CVS HEALTH Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVS shares.

Notify only if

Insider Trading

Get notified when an Cvs Health Corp insider buys or sells CVS shares.

Notify only if

News

Receive news related to CVS HEALTH Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CVS